Remarkably, the sensitivity analysis for patients prescribed exendin-based GLP-1 RAs, contraindicated in cases of severe renal insufficiency (eGFR <30 ml/min/1.73m2 according to current clinical recommendations)19,20, also corroborated the primary analysis’s results (Table S8-9). This evidence concerns the gene GCG and Renal insufficiency.